Exercise :: New study weighs benefits of exercise, diets
While exercise and weight loss are equally effective ways to lose weight, exercising helps to maintain muscles, new research finds.
While exercise and weight loss are equally effective ways to lose weight, exercising helps to maintain muscles, new research finds.
New research at Wake Forest University School of Medicine suggests that certain inhaled asthma medications — as well as similar chemicals our bodies produce during times of high stress — may worsen diseases such as asthma, heart failure and lupus that involve inflammation.
UCLA researchers in collaboration with researchers at Rutgers University have solved longstanding mysteries surrounding DNA transcription, the first step in carrying out instructions contained in our genes.
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced the results of a study which suggested that stimulant medications such as ADDERALL XR? (mixed salts of a single-entity amphetamine product) are significantly more effective than non-stimulant medications in the treatment of patients aged 8 to 15 with Attention-Deficit/Hyperactivity Disorder (ADHD).
The answer to one of the world’s largest problems — the need for clean, renewable sources of energy — might just come from some of the world’s smallest inhabitants — bacteria — according to a new report, “Microbial Energy Conversion,” released by the American Academy of Microbiology.
Money changes everything, and that includes changing people’s motivations for the better and their behavior toward others for the worse, according to a new study published in the international journal Science.
A team of scientists, including four at The Johns Hopkins University, has discovered two new subatomic particles, rare but important relatives of the familiar, commonplace proton and neutron.
Geologists have developed a new theory to explain how and when the Appalachian Mountain range was created. Their research redraws the map of the planet from 420 million years ago.
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that a single once-daily morning dose of the investigational amphetamine compound SPD465, extended release triple-bead mixed amphetamine salts, designed to reduce symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults for up to 16 hours, was bioequivalent to a dose of ADDERALL XR (mixed salts of a single-entity amphetamine product) followed by a dose of mixed amphetamine salts immediate release (“MAS IR”) eight hours later.
Researchers at the University of Minnesota’s Institute for Human Genetics have shown for the first time that the severity of an adult neurodegenerative disease is tied to how well the brain developed shortly after birth.